Search Results 1121-1130 of 15426 for alt

1. A Study Of CSF-1R Inhibitor, AXatilimab For GVHD After HLA-matched Related And Unrelated Donor Allogeneic Stem Cell Transplantation (ABRAXAS) - Mayo Clinic

   Alanine aminotransferase (ALT) and aspartate transaminase (AST) ≤2.5 x ULN). Calculated creatinine clearance ≥30 mL/min using the Cockcroft-Gault formula.

2. VAL-083 Phase 3 Study in Temozolomide-Avastin (Bevacizumab) Recurrent GBM - Mayo Clinic

   AST, ALT must be <2 x ULN. Total bilirubin <1.5 x the institutional ULN, unless the subject has documented unconjugated bilirubin disorder such as Gilbert's ...

3. A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local Therapies (ARASTEP) - Mayo Clinic

   * Screening values of: Alanine aminotransferase (ALT) ≤1.5 x upper limit of normal (ULN); Aspartate aminotransferase (AST) ≤1.5 x ULN; Total bilirubin ...

4. A Study to Evaluate ALZT-OP1a in Subjects with Mild-to-Moderate Amyotrophic Lateral Sclerosis - Mayo Clinic

   Moderate-to-severe liver disease: aspartate aminotransferase (AST), alanine aminotransferase (ALT), or bilirubin concentrations > 3 times the upper limit of ...

5. A Study of Trametinib in Treating Patients With Epithelioid Hemangioendothelioma That Is Metastatic, Locally Advanced, or Cannot Be Removed by Surgery - Mayo Clinic

   Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) =< 2.5 x institutional ULN (within 2 weeks of patient registration [for blood results] and ...

6. A Study to Determine the Effectiveness and Safety of Oral Edaravone Administered in Subjects with Amyotrophic Lateral Sclerosis - Mayo Clinic

   Subjects who have alanine aminotransferase (ALT) or aspartate aminotransferase (AST) elevations greater than 2 times the upper limit of normal (ULN) at ...

7. Gemcitabine Hydrochloride Alone or With M6620 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer - Mayo Clinic

   ... (ALT) (serum glutamate pyruvate transaminase [SGPT]) =< 2.5 x institutional upper limit of normal. Within 2 weeks prior to initiation of study treatment ...

8. Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3) - Mayo Clinic

   Bilirubin > 1.5 x Upper Limit of Normal (ULN); AST and/or ALT > 2.5 x ULN; and; Serum creatinine > 1.5 x ULN. History of significant cardiovascular disease ...

9. A Safety to Evaluate the Safety and Effectiveness of Pressurized Intraperitoneal Aerosolized Chemotherapy in Ovarian, Uterine, Colorectal, and Gastric Cancer Patients - Mayo Clinic

   ... ALT must be =< 5 x ULN; Alkaline phosphatase =< 2 x ULN; Serum creatinine (sCr) =< 1.5 x ULN, or creatinine clearance (Ccr) >= 40 ml/min as calculated by the ...

10. Filgotinib In The Induction And Maintenance Of Remission In Adults With Moderately To Severely Active Ulcerative Colitis - Mayo Clinic

    Hepatic panel (AST, ALT, total bilirubin) ≤ 2 times the ULN;; Estimated CrCl ≥ 40 ml/min as calculated by the CC&G equation;; Hemoglobin ≥ 8 g/dL;; Absolute ...